Complete the pre-quiz poll to access the course episodes.
It is the policy of AcademicCME that all faculty, instructors, and planners disclose relevant financial relationships with ineligible companies. Planners have no relevant financial relationships with ineligible companies to disclose related to this activity. Faculty
have disclosed the following relevant financial relationships. All relevant financial relationships have been mitigated.
| Faculty | Relationship Identified With: |
| Mazen Hanna, MD | Consultant/Advisor: Akros Pharma Inc.; Alexion Pharmaceuticals, Inc; Alnylam Pharmaceuticals; AstraZeneca; Attralus, Inc.; Avidity Biosciences; Cytokinetics; BioMarin; BridgeBio Pharma, Inc.; Bristol-Myers Squibb Company; Edgewise Therapeutics; Haya Therapeutics; Ionis Pharmaceuticals; Lexicon Pharmaceuticals, Inc.; Lexeo Therapeutics, Inc.; Neurimmune; Pfizer Inc.; Prothena; Rocket Pharmaceuticals, Ltd; Tenaya TherapeuticsGrant/Research Support: Attralus, Inc.; Cytokinetics; Ionis Pharmaceuticals; Johnson & Johnson Services, Inc.; Pfizer Inc. |
| Ahmad Masri, MD, MS | Consultant/Advisor: Alexion Pharmaceuticals, Inc; Alnylam Pharmaceuticals; Attralus, Inc.; BridgeBio Pharma, Inc.; Pfizer Inc.; Novo Nordisk A/S |
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; Nicole McMenamin and Chelsey Simonds hereby state that they do not have any relevant financial relationships to products or devices with any commercial interests related to the content of this activity.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been supported by an independent educational grant from Alnylam Pharmaceuticals.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. AcademicCME and Alnylam Pharmaceuticals do not recommend the use of any agent outside of the labeled indications.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
For all CE inquiries or special needs, please contact admin@academiccme.com.
811 S. Orleans Ave. Tampa, Fl 33606
